Literature DB >> 3863543

The effects of naloxone in Tourette's syndrome.

R Sandyk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3863543     DOI： 10.1002/ana.410180322

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  6 in total

Review 1.  The biochemistry of Tourette's syndrome.

Authors:  P R Chokka; G B Baker; R A Bornstein; C M de Groot
Journal:  Metab Brain Dis       Date:  1995-06       Impact factor: 3.584

2.  Further speculations on possible dopamine-opioid link in autism.

Authors:  R Sandyk
Journal:  J Autism Dev Disord       Date:  1986-03

Review 3.  Pharmacological options for the treatment of Tourette's disorder.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Psychopharmacology of tic disorders.

Authors:  Myriam Srour; Paul Lespérance; Francois Richer; Sylvain Chouinard
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2008-08

5.  Tourette syndrome: successful treatment with clonidine and oxycodone.

Authors:  R Sandyk
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

6.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.